Wie hoch ist der Preis für General Biologicals Corporation (4117)

Preis für General Biologicals Corporation (4117) ist $0.31640033

Wie hoch ist die Marktkapitalisierung für General Biologicals Corporation (4117)

Marktkapitalisierung für General Biologicals Corporation (4117) ist $22.25M

General Biologicals Corporation (4117) Operative Marge

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.

Jahr	Operative Marge	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Operative Marge

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Operative Marge	Differenz der operativen Marge	Land
STERIS plc STE.US	18.91%	-	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0.00%	-	CN
Ypsomed Holding AG YPSN.SW	0.00%	-	CH
Medacta Group S.A. MOVE.SW	0.00%	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0.00%	-	CN

Unternehmen

Operative Marge

Differenz der operativen Marge

Land